Is molnupiravir effective in treating high fever due to lung infection?

Molnupiravir capsules (Molnupiravir) is a new type of antiviral drug, mainly used to treat COVID-19. Its mechanism of action is to inhibit the growth and replication of the virus by interfering with the viral RNA replication. While monogravir capsules have shown therapeutic potential against COVID-19 in some studies, they are not specifically designed to treat high fever or lung infections caused by the virus. Some key information related to monogravir capsules and COVID-19 will be explained below.

1. Therapeutic potential forCOVID-19: Monoravir capsules are mainly researched and developed for the treatment of COVID-19. Viral infections are often accompanied by a series of symptoms, including fever, cough, shortness of breath, etc., and high fever is usually one of the symptoms. The goal of monogravir capsules is to reduce symptoms, shorten the duration of illness, and reduce the risk of hospitalization and death. However, it is not an antipyretic or antipyretic and its main mechanism is to inhibit viral replication.

2. Treatment of high fever and lung infection: High fever and lung infection usually require comprehensive treatment, and the specific treatment plan usually depends on the cause of the infection. Bacterial lung infections are usually treated with antibiotics, while viral lung infections may require other types of antiviral medications. Antipyretics and medications to reduce fever symptoms may also be considered by your doctor. However, the main use of monogravir capsules is to treat COVID-19, so doctors often consider other treatment options when dealing with high fever or lung infection.

3. Individualized treatment: It is important that each case is unique and treatment should be individualized based on the patient's specific circumstances. If patients develop symptoms such as high fever or lung infection, they should consult a doctor as early as possible for a comprehensive evaluation and diagnosis. Your doctor will consider the cause, medical history, severity of symptoms, and other factors to determine the most appropriate treatment plan.

In short, monogravir capsules are a drug used to treatCOVID-19. Its main effect is to inhibit the replication of the virus, rather than a specific treatment for high fever or lung infection. For symptoms such as high fever or lung infection, patients should consult a doctor to obtain individualized treatment suggestions and conduct treatment according to the doctor's recommendations.

Monolavir capsules are already on the market in China, but they are not yet included in medical insurance. Please consult your local hospital pharmacy for specific prices. The cheaper ones abroad are Indian generic drugs, which cost around three to four hundred yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.